Educational Series - Personalising first-line treatment for chronic lymphocytic leukaemia

The review provides a background on CLL in Australia, treatment goals and importance of specialisation, it also explores relevant studies and implementing flexible care pathways.

It includes guiding commentary from Professor Stephen Opat, the Cancer Program Director at Monash Health and a Clinical Professor in the School of Clinical Sciences at Monash University.

Please login below to download this issue (PDF)

Subscribe